WITHDRAWN: A novel mitochondrial DNA deletion in a patient with Pearson syndrome and neonatal diabetes mellitus provides insight into disease etiology, severity and progression.

[1]  Robert W. Taylor,et al.  Disease progression in patients with single, large-scale mitochondrial DNA deletions , 2013, Brain : a journal of neurology.

[2]  J. Hayashi,et al.  Mitochondrial DNA with a Large-Scale Deletion Causes Two Distinct Mitochondrial Disease Phenotypes in Mice , 2013, G3: Genes, Genomes, Genetics.

[3]  A. Malik,et al.  Is mitochondrial DNA content a potential biomarker of mitochondrial dysfunction? , 2013, Mitochondrion.

[4]  J. Abdenur,et al.  Pearson syndrome: unique endocrine manifestations including neonatal diabetes and adrenal insufficiency. , 2012, Molecular genetics and metabolism.

[5]  W. Craigen,et al.  Sequence Homology at the Breakpoint and Clinical Phenotype of Mitochondrial DNA Deletion Syndromes , 2010, PloS one.

[6]  Robert W. Taylor,et al.  The investigation and diagnosis of pathogenic mitochondrial DNA mutations in human urothelial cells. , 2010, Biochemical and biophysical research communications.

[7]  A. Munnich,et al.  Pearson Syndrome in the Neonatal Period: Two Case Reports and Review of the Literature , 2009, Journal of pediatric hematology/oncology.

[8]  Hsiu-Fen Lee,et al.  The neurological evolution of Pearson syndrome: case report and literature review. , 2007, European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society.

[9]  Tadafumi Kato,et al.  Co‐existing point mutations of mitochondrial DNA in a patient with a heart abnormality and Pearson syndrome‐like symptoms , 2005, American journal of medical genetics. Part A.

[10]  B. Glaser,et al.  Glibenclamide treatment in permanent neonatal diabetes mellitus due to an activating mutation in Kir6.2. , 2004, The Journal of clinical endocrinology and metabolism.

[11]  C. Lam,et al.  Pearson's syndrome: a rare cause of non-immune hydrops fetalis. , 2003, Chinese medical journal.

[12]  P. Tonali,et al.  Pathogenic role of mtDNA duplications in mitochondrial diseases associated with mtDNA deletions , 2003, American journal of medical genetics. Part A.

[13]  Y. Goto,et al.  The association between haematological manifestation and mtDNA deletions in Pearson syndrome , 1997, Journal of Inherited Metabolic Disease.

[14]  M. Forest,et al.  Identification of a large-scale mitochondrial deoxyribonucleic acid deletion in endocrinopathies and deafness: report of two unrelated cases with diabetes mellitus and adrenal insufficiency, respectively. , 1997, The Journal of clinical endocrinology and metabolism.

[15]  P. Lamont,et al.  Pearson’s syndrome without marrow involvement , 1997, Archives of disease in childhood.

[16]  T. Bourgeron,et al.  Spectrum of mitochondrial DNA rearrangements in the Pearson marrow-pancreas syndrome. , 1995, Human molecular genetics.

[17]  A. Munnich,et al.  3-Methylglutaconic aciduria associated with Pearson syndrome and respiratory chain defects. , 1992, The Journal of pediatrics.

[18]  D. Wallace,et al.  Maternally transmitted diabetes and deafness associated with a 10.4 kb mitochondrial DNA deletion , 1992, Nature Genetics.

[19]  F. Ledeist,et al.  Pearson's marrow-pancreas syndrome. A multisystem mitochondrial disorder in infancy. , 1990, The Journal of clinical investigation.

[20]  A. Fischer,et al.  Tubulopathy and pancytopaenia with normal pancreatic function: a variant of Pearson syndrome. , 2009, European journal of medical genetics.

[21]  E. Brett,et al.  Pearson syndrome and mitochondrial encephalomyopathy in a patient with a deletion of mtDNA. , 1991, American journal of human genetics.